Pressreleases, rapporter och nyheter för Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Germanys intention to legalize cannabis is a gamechanger for Europe
Press release from Companies: DanCann Pharma A/S: CEO, Jeppe Krog Rasmussen (Xignotus Capital ApS), locks his position in DanCann Pharma for 3 years - and thereby more than 21% of the total share capital
Press release from Companies: DanCann Pharma A/S: It's official: A permanent scheme for medical cannabis in Denmark
Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™
Press release from Companies: DanCann Pharma A/S publishes Q3-2021 report
Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF™ from the European Medicines Agency
Press release from Companies: DanCann Pharma A/S: Correction: Flagging announcement in DanCann Pharma A/S
Press release from Companies: Flagging announcement in DanCann Pharma A/S
Press release from Companies: DanCann Pharma A/S Announces Closing of the Previously Announced Acquisition of CannGros ApS
Press release from Companies: DanCann Pharma A/S: Medicinal cannabis bill is an important step in the right direction
Press release from Companies: Correction: DanCann Pharma A/S acquires CannGros ApS and becomes market leader in the Danish market under the Pilot Programme with Medical Cannabis
Press release from Companies: DanCann Pharma A/S successfully completes a directed issue of units of approx. 8 MDKK
